Glenn Ellis, MPH, CHCE is a health educator, lecturer, and syndicated health columnist. Ellis is a Visiting Scholar at the National Bioethics Center at Tuskegee University and was a Research Bioethics Fellow at Harvard Medical School. A native of Birmingham, Alabama, Glenn Ellis was a Pre-Med undergraduate at the University of Pennsylvania, did his Hospital […]
David Winickoff heads the Secretariat of the Working Party on Bio-, Nano-, and Converging Technology (BNCT) at the Organisation for Economic Cooperation and Development (OECD). In this capacity he leads research, policy work, and soft law development in the area of science, technology, and innovation at the national and international levels. He is a graduate of Harvard Law School […]
Dr. Ouedraogo is as a scientist in genetics and plant breeding and got his PhD in Canada. He focused his research on the use of biotechnology and biosafety tools in crops. As a plant breeder, he has established the Plant Genetics and Biotechnology laboratory in the national research system of Burkina Faso. He has contributed […]
Shahram is Founder/ General Partner at Civilization Ventures (inquiries to info@civilizationventures.com), a venture capital firm focused on supporting cutting-edge innovations in health tech and biology. Prior to CV, Shahram was a serial entrepreneur and founding executive in several life science companies, raising over $100M. Shahram was the founding CEO of Rgenix, a clinical-stage biotech company with multiple […]
Brantley Browning is a Senior Program Officer at the Bill & Melinda Gates Foundation, focusing on policy, advocacy, and communications for agricultural development in Sub-Saharan Africa and South Asia. Previously, Brantley worked at Starbucks Coffee Company, where he was responsible for integrating social and economic development programs within coffee, tea, and cocoa producing communities.. Brantley worked for […]
Dr. Anne Cheever joined DARPA as a program manager in August 2020. Prior to joining DARPA, Cheever was a lead biotechnologist at MITRE Corporation, where she provided scientific and strategic support to multiple federal institutions in the areas of biodefense, biosecurity, disruptive technologies, and emerging infectious disease. She also led a team focused on COVID-19 […]
Rena M. Conti is the Associate Research Director of Biopharma & Public Policy for the Boston University Institute for Health System Innovation & Policy. She is also an Associate Professor at the Boston University Questrom School of Business. From 2006 through June 2018, Professor Conti was an Associate Professor of Health Economics and Policy at […]
Elissa spent the past 12 years launching specialty therapeutics and initiatives in the bio-pharmaceutical industry and developing economic policy in the public sector. She most recently lead patient strategy and digital innovation for biosimilar immunology products at Merck, brought their ground-breaking immunotherapy cancer treatment to market and developed their first 24/7 patient support program. Elissa […]
Sharon F. Terry is President and CEO of Genetic Alliance, an enterprise engaging individuals, families and communities to transform health. Genetic Alliance works to provide programs, products and tools for ordinary people to take charge of their health and to further biomedical research. As ‘just a Mom’ with a master’s degree in theology, she cofounded PXE International, a research […]
Larry Au is a Ph.D. candidate in sociology with broad interests in political sociology, economic sociology, and science and technology studies. His dissertation examines the global emergence of the techno-scientific field of precision medicine, focusing on the construction of large speculative infrastructures for biomedical research in China. His other projects examine the translation of “good […]